Analyst Price Target is $10.50
▲ +152.46% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Eupraxia Pharmaceuticals in the last 3 months. The average price target is $10.50, with a high forecast of $12.00 and a low forecast of $9.00. The average price target represents a 152.46% upside from the last price of $4.16.
Current Consensus is
Strong Buy
The current consensus among 4 contributing investment analysts is to buy (strong buy) stock in Eupraxia Pharmaceuticals.